Our non-contact, non-invasive biomarker measurement system, “FLD-A1c®,” has been implemented in an area accessible to researchers, including professors from the University of Tokyo, on one of its major campuses. It is specified that this is part of a collaborative project between our company and the University of Tokyo. We will continue to advance joint projects …
We has been advancing the development of the FLD® series, which enables contactless and non-invasive measurement of various indicators (biomarkers), including more advanced metrics such as HbA1c, not just oxygen saturation. The development is focused on two main axes: multi-architecture and simultaneous multi-item measurement. Based on this development plan, we have successfully developed the function …
Read more “Development of the iPhone and Android Versions for the FLD® Series HbA1c”
SFM Co., Ltd. has entered into a special agreement with The University of Tokyo (hereinafter referred to as “the University”) with a view towards a new industry-academia collaboration project through joint research. In order to further advance the educational and research environments of the University’s main campuses, we aim to integrate our biomarker measurement technology, …
Our company has successfully registered the trademark for the “FLD-A1c” (this product), the first in the FLD series of non-contact, non-invasive intravascular biomarker analysis devices, with the Patent Office as part of our initiative to strengthen industrial property rights. This registration grants us exclusive commercial rights to the trademark in addition to our prior user …
Read more “Regarding the Completion of Trademark Registration for “FLD-A1c””
The article introduces our “Future Laboratory Data® (FLD®) series,” which enables the non-contact, non-invasive, and highly accurate measurement of biomarkers in the blood.
In the article in question, our new product, the “FLD™ (Future Laboratory Data™) Series,” is featured across a two-page spread. Additionally, a graph comparing and analyzing blood test data is included in the content.
Our company will launch the “FLD-A1c™,” the first in the “Future Laboratory Data™ Series” of new products capable of measuring biomarkers in a non-contact and non-invasive manner. Product Overview The “FLD-A1c™” device enables immediate measurement of pulse rate, oxygen saturation, and Hemoglobin A1c (HbA1c) simply by standing approximately 1 to 1.5 meters in front of …
Read more “The launch of the first product in the “Future Laboratory Data™ Series” has begun.”
As part of a collaborative project with the Tokaido Shinkansen and Sanyo Shinkansen, our company’s business is featured in the business magazine “Wedge” (January 2023 issue), which is placed in all seats of the Green Cars on the Nozomi, Hikari, and Kodama trains. This article will be displayed for one month, including the end of …
Happy New Year. We would like to express our deepest gratitude for your exceptional support and consideration throughout the past year. We look forward to your continued support and patronage in 2023.